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Introduction
Nearly all study ofthe health consequences
of environmental and lifestyle exposures in
human populations is purely observational.
This means that the validity ofthe compari-
son of disease rates between more exposed
and less or nonexposed persons is dependent
on the assumption that disease rates in the
two groups are comparable in the absence of
such exposure. This comparability assump-
tion can be weakened somewhat by the
measurement and accommodation ofother
factors that are associated with disease risk
and that have a different distribution in the
compared exposure groups. If such con-
founding factors are accurately measured
and adequately acknowledged in the data
analysis, it is then sufficient that in the
absence of the exposure of interest, the
groups being compared have common dis-
ease rates conditional on the values of the
confounding factors. Lack ofvalidity (i.e.,
bias) in testing or estimation can be expected
ifthere are unidentifiedconfoundingfactors, if
therecordedconfoundingfictorsaremeasured
with error, or ifthe treatment ofindividual
confounding factors is inadequate (e.g., linear
allowance for confounders having effects that
are substantially nonlinear). Bias also can be
introduced ifthe exposure variables ofinterest
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or the health effects under study are not mea-
sured accurately. In practice these sources of
bias can be reduced, but it is unlikllythatthey
willbecompletelyeliminated.
The sources of bias mentioned here are
the principal reasons why epidemiologic
cohort studies, among others, may yield
inaccurate and conflicting results. Concern
about residual, uncontrolled confounding
can never be completely eliminated in any
nonexperimental study. Hence, such stud-
ies are most reliable for the detection of
moderate to large health effects (e.g.,
increase in disease incidence by a factor of
two or more among highly exposed per-
sons) that are unlikely to be qualitatively
affected by modest confounding. There is
also a strong role for the replication of
results in diverse populations that are pre-
sumed to have different potentials for
severe confounding. It is worth noting that
experimental studies also have important
practical limitations in the context ofenvi-
ronmental epidemiology. Data analysis
methods for cohort studies with accurate
and complete assessment of exposure vari-
ables, confounding factors, and potential
health consequences are well developed, as
summarized in"Exposure-Response Estimate
in Cohort Studies," below.
Case-control studies inwhich exposure and
confounding factors are assessedretrospectively
are subject to all ofthe biases noted above, as
well as to recall bias, which occurs when dis-
eased individuals (cases) and disese-free indi-
viduals (controls) differentially recall their
exposures, their confounders, or their health
outcome. Aggregate datastudies, referred to
later in this paperas ecologicstudies, attempt
to relate the exposure andconfoundingfactor
experience ofgroups to their corresponding
disease rates. Such studies may be subject to
additional biases if the statistical model for
the group disease rate does not equal the
average ofvalid disease rate models for the
individualsbeingaggregated.
Apparent disagreement between environ-
mental epidemiologic studies can also arise,
not from bias, but from lack ofpower com-
binedwith attention to point estimates rather
than confidence limits. The ability to detect
an association between the levels ofan expo-
sure variable or exposure history and the risk
ofadiseasedepends primarilyon theobserved
numberofdisease events in the studysample,
on the range ofexposures in the sample, and
on the strength ofassociation between expo-
sure and disease. The distribution ofexpo-
sures in the study cohort or in the cohort
fromwhich cases and controls are selected for
a case-control studyalso has important influ-
ences on study power. While random mea-
surement error in (univariate) exposure
assessment will not invalidate, under weak
conditions, a test for the hypothesis that no
association between exposure and disease
exists, test power may be reduced consider-
ably by such measurement errors. Also, esti-
mates ofdose-response parameters may be
substantially distorted (usually biased down-
ward), induding the possibility of a loss of
monotonicity ofdose-response trends (1).
Thus, the proper analysis and interpretation
ofenvironmental epidemiologic studies rely
heavily on the investigator's assessment ofthe
magnitude ofboth potential biases and study
power in the absence ofsuch biases. For
practical reasons, the power ofspecific stud-
ies will often be rather low, and knowledge
of disease mechanisms and measurement
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properties will be too limited to place usefid
bounds on potential biases. Hence, there are
important uses for formal tests ofthe equality
ofexposure-disease associations from two or
more studies in differing populations and for
techniques used in combining the results of
several studies. This topicwill bediscussed in
thesection tided "ComparingandCombining
the Results ofSeveral Studies."
The following section describes statistical-
and biological-based models that can serve
as the basis forexposure-disease analyses.
Modelsfor Disease
Occurrence
The simplest cohort studies occur when
exposure takes place in one instant, as in
Japanese atomic bomb survivors, or is con-
stant over the individual's lifetime, as in
some animal inhalation experiments.
However, most exposures, and most con-
founders, are complex functions of time
and demand a more complicated mathe-
matical description. Our discussion of
descriptive disease occurrence models
begins with the over-simplified case.
Let ko(t) denote the instantaneous rate
of occurrence of a study disease or other
health-related event for subjects of age t
who have not received the exposure of
interest. This means that if Nsuch per-
sons, all at age t, were observed for a short
time dt, the expected number of disease
occurrences would be NXO(t)dt. Ifa per-
son of age t received an exposure Z, the
instantaneous occurrence rate would be
altered from ko(t) to k(t Z), the (instan-
taneous) relative risk is X(t;Z) / ko(t).
These rates are nonnegative and, provided
neither is zero, one can take the logarithm
of this relative risk. It is often convenient
and useful to assume the logarithm of the
relative risk to be a linear function ofexpo-
sure and confounding factor measure-
ments. This is equivalent to modeling the
relative risk as an exponential function,
exp(XP), where the vector X = (X1,,..,X
which replaces the more general Z, consists
of carefully chosen (and usually incom-
plete) measures ofexposure or confounding
factors, with X = (0,...,0) corresponding to
no exposure and standard values for con-
founders. The coefficients (P1,...,),
regression coefficients that comprise the
vector P (or, more precisely, its transpose
T), then tell us about the impact ofeach
Xi on relative risk when the other Xs are
held fixed.
The result is asimple proportional hazards
(or Cox) model
X(tIZ) +ko(t)exp(Xi) [1]
which is used widely in the analysis offail-
ure time data (2). In order to deal with
complications inherent in most environ-
mental epidemiologic studies, one must
generalize this discussion and complicate
the appearance of some formulae, but be
careful not to change the essentials of the
approach. Such generalization follows in
the next subsection.
Descriptive Relative-RiskModels
As above, let k0 (t) denote the instanta-
neous rate of a study disease (or other
health-related problem) at age t in the
absence of the exposure ofinterest. A per-
son of age t may have received exposures
z(u) at certain ages u < t. One can refer to
Z(t) = {z(u), u < t} as the person's expo-
sure history up to age t. Furthermore, one
can allow the vector z(u) to indude the val-
ues ofconfounding factors at age u, so that
Z(t) indudes both exposure and confounding
factorhistories up toage t. Thediseaserateat
age tis X{tIZ(t)}, a function ofthis exposure
and confounder history. Therelativeriskasso-
ciated with history Z(t) is then the ratio
X{tIZ(t)}/ ko(t). Because this ratio is non-
negative, it can be, andoften is, modeled using
an exponential function exp{X(t)P}, where
X(t) = {X1(t),...,X(t)}. This function con-
sists ofdata-analyst-defined functions ofZ(t)
and t, with X(t) (0...0) again correspond-
ing to no exposure and standard confounder
histories, while pT= (Pi'. . is a corre-
sponding vector ofrelative-risk parameters to
be estimated.
This relative risk (RR) regression model
X{tIZ(t)} = X0(t)exp{X(t)P} [2]
also called the Cox-regression model or
(inaccurately called) the proportional haz-
ards model (2-4) or an approximation to
these models, forms the basis for most
descriptive analyses of environmental epi-
demiologic studies. As a simple example to
illustrate the notation, consider the relation-
ship between exposure to ionizing radiation
and the rate ofa certain cancer in the atomic
bomb-exposed populations in Hiroshima
and Nagasaki. One could define
z(u0)T = {Z1(U0),Z2(U0)}, [3]
as the gamma and neutron exposures for a
person at age u0 in 1945 when the exposure
occurred and as z(u) _ 0 otherwise. A speci-
fication X(t) _ z(u0) then assumes a log-rela-
tive risk function that is linear in gamma and
neutron exposure levels. The regression
model can be relaxed to allow, for example,
the relative risk to depend on age at exposure
andtimesinceexposureand toallowfornon-
linear dependencies ofthe log-relative risk on
gammaandneutron exposure.
As noted above, the histories ofpotential
confounding factors can also be induded in
Z(t), in which case X(t) will indude func-
tions of both the exposures of interest and
other factors, while product terms between
the two will allow the relative risk associated
with a given exposure history to depend on
the value ofother variables. This allowance
is termed effect modification in epidemio-
logic parlance. Confounding factors may
also be controlled by means ofstratification
rather than, or in addition to, regression
modeling using the descriptive model
X{ttZ(t)} =Xo,(t)exp{X(t)P} [4]
where thebaseline rateX4(o) is allowed tovary
across a number ofstrata defined as functions
ofage(4andconfoundingfactorvalues.
Relative-risk forms other than exponential
also maybe considered in the above models.
In particular, the linear form 1 +X(t)p often
is felt to be theoretically and empiricaly
more appropriate for certain carcinogenic
exposures and has been usedwidely in radia-
tion literature, sometimes with the addition
of quadratic terms. Absolute rather than
relative-risk models, such as
{,tIZ(t)} =X?"(t) + X(t)P, [5]
also have been used in modeling radiation
effects, although there is a consensus that it
generally does not fit well without the addi-
tion ofterms for themodifying effect ofage
at exposure and latency. It may also be use-
ful formodeling certain rare diseases such as
mesothelioma, for which the baseline rate
in the absence ofasbestos exposure is virtu-
ally zero. In all ofthese alternatives to the
standard exponential relative-risk model,
estimates ofthe relative-risk parameters and
baseline rates are often found to have poor
statistical properties. However, quite general
programs that use likelihood-based methods
to obtain appropriate confidence limits (5)
are nowavailable tofit abroadclassofrelative-
andabsolute-riskmodelswithcombinations of
linearandexponential terms.
Suppose that the regression vector X(t)
in the above unstratified model consists
only of functions of the exposure variable
under study, and let pr{X(t)} denote the
probability density for value X(t) in the
source population of the modeled regres-
sion vector. In addition to estimating the
relative-risk function, one may be inter-
ested in the fraction of the disease inci-
dence at age t that may be attributed to
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exposure. Ifthe disease rate for all studysub-
jects was reduced to the baseline rate 4(t),
then the overall incidence at age twould be
reduced bytheattributable proportion
AR(t) = JXo(t) [exp{X(t)P}-1]
pr{X(t)}d%(t)/JXo(t)
exp{X(t) }pr{X(t)}d%(t). [6]
A similar expression can be written for the
attributable proportion under the stratified
relative-risk model.
In some applications ofthese relative-risk
models, it is convenient to define the basic
time variable t to be chronological time or
time from entry into a certain cohort rather
than age, which is accommodated through
stratification or regression modeling. For
example, in a cohort study with covariate
information collected at specified points in
chronological time, such a definition can
help ensure comparability of the covariate
(i.e., exposure andconfounding) information
on all studysubjects at agivenvalue oft.
There are distinct advantages in using haz-
ard rates or instantaneous disease rates,
X{tIZ(t)}, in our formulae rather thanddis-
ease rates over some specified age or time
period, in part because the interpretation of
these latter rates will depend on the duration
ofthe age period or time period in question,
which will vary inevitably from study to
study. Nevertheless, in some studies one
observes onlywhether disease occurs in a cer-
tain time period rather than the actual times
or ages of disease occurrence. Let D = 1
denote disease occurrence during aprescribed
disease ascertainment period for a study and
D = 0 denote lack of occurrence. Ignoring
issues such as competing risks and losses to
follow-up, one may choose to model the dis-
ease probabilities pr{D = IIZ(tO)} by an
exponential-form odds-ratio model inwhich
pr{D = 1IZ(to)1 / prD= 1IZ(to) = Zo
pr{D = ° Z(to)1 / pr{D= OZ(to) = Zo}
= exp{X(to)|}, [7]
where Z(to) denotes a subject's exposure
and confounding factor history at age to at
the beginning of the ascertainment period,
and ZO denotes the standard, or base,
covariate history. This odds-ratio model can
be rewritten as alogistic regression model
pr{D = 1 iZ(to)i
= exp{a(Zo) + X(to)P}
/ [I + exp{a(ZO) +X(to)tp}], [8]
where the function a(ZO) may, for example,
be defined to takevaluea,whenever thestudy
subject falls in stratum s, which is defined as
a function ofpotential confounding factor
values atto.
The above relative-risk and odds-ratio
models are purely descriptive models.
Their application is intended as an aid for
summarizing and displaying aspects of
large, complex data sets. In some situa-
tions, such as a regulatory decision con-
cerning the safe level ofa certain exposure,
it will be essential to bring to bear any
available biologic or mechanistic knowl-
edge on the inference problem. Such
knowledge could be used, for example, to
specify a form for the relative risk at age t
as certain elements ofX(to) approach zero,
where theseelements capturethedosage, dura-
tion, or other aspects ofthe exposure in ques-
tion. Similarly, knowledge or assumption
about the pertinent biological mechanisms
could be used to derive models forX{tIZ(t)}
offorms other than those mentioned above.





Efforts to describe a disease process in terms
of deterministic or stochastic models have
focused mostly on models for the spread of
infectious diseases in apopulation and mod-
els for carcinogenesis. Some ofthe work on
carcinogenesis models, as outlined below,
maybe pertinent to other diseases.
Much ofthe earlywork on mathematical
models for cancer was reviewed in a classic
paperbyArmitageandDoll (6). Whittemore
and Keller (7) also provide a comprehen-
sive review. A major contribution of the
Armitage and Doll paper is the use of the
multistage model of carcinogenesis. This
model is based on the assumptions that
cancer results from a single cell line under-
going a series ofdiscrete, heritable changes
(e.g., point mutations, chromosomal breaks
or translocations, or other types ofcopying
errors) in a particular sequence, and the
rates of such transitions do not depend
explicitly on age, although they may be
affected by exposure to carcinogens or by
factors that modify the rate ofcell division.
As a consequence of these and some addi-
tional assumptions, it can be shown that
the age-specific incidence rate is predicted
to vary approximately as the (k-i)stpower
ofage, where kis the number oftransitions
required (usually estimated to be about 5
to 7 for adult tumors). If a carcinogenic
exposure occurs at a constant rate over time,
the incidence will vary approximately as a
polynomial function of dose rate of order
equal to the number of dose-dependent
transitions. Ifexposure is instantaneous or
varies over time, the incidence rate will be
modified by age at exposure and/or time
since exposure, depending upon which
stage(s) is dose-dependent.
Until recently, most of the empirical
tests ofthese predictions have been done by
fitting the model to aggregate data on pop-
ulation age-specific rates, or to broadly-
grouped data on cohorts, stratified by dose,
age at exposure, or time since exposure. A
problem with this approach is the difficulty
ofseparating the effects ofdose rate, age at
first exposure, duration of exposure, time
since last exposure, and attained age, all of
which influence the predictions of the
model. Simple comparisons of one factor
without controlling the other factors can be
misleading. This is less ofa problem when
animal bioassay data are used, as these are
usually limited to constant, lifetime, dose
regimens. However, such data are not
informative about whether the carcinogen
acts at an early or late stage. Nevertheless,
the approach has been used for risk-assess-
ment purposes by many regulatory agencies.
The default approach advocated by the U.S.
Environmental Protection Agency (EPA) and
others involves fittingthemultistage model to
available epidemiologic or toxicologic data
and using an upper confidence limit on the
estimated slope coefficient (scaled for species
differences in weight and life span) to com-
pute the lifetime excess risk in humans. The
scientific and statistical validity of this
approach is controversial (8,9).
With the development of general rela-
tive-risk models ("Descriptive Relative-Risk
Models" above), it has become possible to
test the multistage and other models by fit-
ting them directly to data on individuals.
This offers great advantages for dealing
with time-dependent exposures, which are
the most informative about the stage at
which a carcinogen acts. This approach has
been applied to data on occupational expo-
sures to asbestos (10), arsenic (11), and ben-
zene (12); on the atomic bomb survivors
(13); and on smoking (14), with varying
results. The three occupational applications
all were consistent with a single stage of
action (relatively late for asbestos and
arsenic, early for benzene), while the radia-
tion and smoking data both showed signs
oftwo stages being affected.
The multistage model has several important
limitations, inlduding its inability to account
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forleukemiaandchildhoodcancers, thegenet-
ics of cancer, and the distinction between
mechanisms ofinitiation and promotion. It
also hasbeen criticized for its need foras many
as 5 to 7 stages to account for the steep age
dependence,whenonlytwo orthreehavebeen
established in experimental systems.
Moolgavkar and Knudson (15) have pro-
posed analtemative model thataddresses these
issues. This model assumes that two muta-
tional eventsarerequiredandthecell linesthat
have experienced the first event may be at a
competitive advantage (proliferation) or disad-
vantage (repair) relative to normal cells.
Carcinogens might act by affecting either
mutation rates or proliferation rates. Major
geneeffectsareaccountedforbyassumingthat
individuals who inherit the gene begin life
with all cells in the intermediate stage. This
model has been successful in fittingepidemio-
logic data on smoking (15,16), breast cancer
(17), and radon (18). In the latter example,
data from an experimental study of rats
expsed to radon were fitted to the model and
radon was found to have an effect on both the
mutation and proliferation rates. However,
the interpretation ofthis result is complicated
by the authors' use, for both ofthese depen-
dencies, ofa power function dose-response
relationship with a very low exponent rather
than a simple linear dose-response. Thomas
(19) has proposed a variant ofthis model that
adds anadditional stage totheprocess to tryto
explain the difference in the modifying effect
ofdose rate and the duration ofexposure for
different types ofradiation; so far, no attempt
hasbeenmadetotest thismodel.
With the rapid growth in our understand-
ingofthefundamentalbiologyofcancer, fur-
ther development of methods to validate
these mechanistic ideas and, where appropri-
ate, to incorporate them into the analysis of
epidemiologic data would be worthwhile.
Most ofthe models that have been consid-
ered seriously are sufficiently general that
some parameter values can be found to pro-
vide an adequate fit to epidemiologic data
sets. Thus, these models are not easily falsi-
fiedas aclass, and it isunlikelythatonecould
choose among them on purely statistical
grounds. Instead, theirutilitylies in the types
ofcomparisons that can be made within the
context ofaparticular model-whether acar-
cinogen acts at an early or a late stage in the
multistage model or as an initiator or a pro-
moter in the two-stage model, for example.
Their real value, therefore, lies in their ability
to organize acomplexsetofhypotheses into a
unified framework and to suggest empirical
tests, inpopulations ofhumans oranimals, of
mechanistic ideas suggested by observations
at the cellular level. Research efforts to iden-
tify and measure the assumed biological enti-
ties on the pathway to cancer cell formation
seemparticularlywellmotivated.
Exposure-esponse
Estimation in Cohort Studies
Rdatve-RiskandOdds-Rado
Estimation
Consider the unstratified relative-risk regres-
sion model of "Relative-Risk Models." A
cohort study involves the selection ofa sam-
ple ofindividuals from the population under
study, succeeded by a follow-up to observe
dease occurrence. The relative-risk parame-
ter P can be estimated by maximig a par-
tial likelihood function L(5) that is aproduct
over all disease occurrence times (ages) that
appear in the sample ofthe ratio ofthe rela-
tive risk for the subject developing disease to
the sum ofthe relative risks for all subjects at
risk at that time (20). The corresponding
likelihood function under the above stratified
relative-risk model is simply the product over
strata ofthe stratum-specific likelihood func-
tions. Note that this estimation procedure is
quite general in that exposure variables, con-
founding variables, and stratum assignments
each canvarywith follow-up time. Theprin-
cipal assumption underlying this estimation
procedure requires the set ofsubjects at risk
for disease at anyfollow-up time to be repre-
sentative ofthe base population, conditional
on the covariate history and stratum assign-
ment. This assumption will be satisfied, for
example, ifstudy subjects are sampled ran-
domly and independently from the study
population, and if rates of censoring (e.g.,
losses to follow-up) at a given follow-up time
depend most on the covariate histories and
stratum assignments at that time. Also,
underweakconditions, L(O) can be manipu-
lated as ifitwere an ordinarylikelihood func-
tion for asymptotic inference on , (21,22).
Variouscomputerprograms areavailable now
forthe estimation ofP, and, therefore, also of
therelative-riskprocessexp{X(t)[B}.
The score statistic U(Io), defined as the
value at X =Poofthederivativewith respect to
, oflogL(Po),can be used tO test X = o. If
Po =0 andX(t) consists onlyofindicatorvari-
ables to distinguish exposure groups, then
U( 0) = U(0) is known as the log rank
statistic. Other choices ofX(t) yield other
amiliar, censored data test statistics, including
generalizationsoftheWllcoxonstatistic.
Suppose now that there is no possibility
of early censorship in the cohort study
throughout the follow-up. The odds-ratio
parameter [ in the logistic regression model
of "Relative-Risk Models," along with the
location parameters a, = a(ZO), can be esti-
mated by a likelihood function L(f) that is
simply the product over all study subjects of
the logistic regression probabilities pr(D =
1I Z(to)) for subjects developing disease, and
one minus such probabilities for other study
subjects. Computer programs are widely
available for inference on , from this likeli-
hood function. Ifthere are fewdisease events
in stratum s, it is preferable to eliminate cxsby
conditioning on the number ofsuch events
prior to applying standard likelihood
procedures fortheestimationofPi (23).
The likelihood functions just described
may seem esoteric to readers not havingasta-
tistical background. The main point to note,
however, is that estimation of relative-risk
and odds-ratio parameters in the very flexible
models of "Relative-Risk Models" is now
routine, and suitable software is available. Of
course, the odds-ratio parameterwill approach
the relative-risk parameter if the disease
acquisition period dt becomes short. This
occurs because theodds ofdisease,
pr{D = 1 IZ(t) / [1 -pr{D = 1IZ(t)1]
[9]
then typically approaches X{tIZ(to)}Id4 from
which the exponential-form odds ratio
approaches a corresponding exponential-form
relativeriskwithidentical regressionparameter.
Estimation of the relative-risk regression
parameter ,B may be computationally
demanding ifthere are many distinct disease
incidence times and ifthe regression vector
and stratum assignment depend on time.
However, ifeachkoX(t) is defined to be con-
stant over apartition ofthe time axis andX(t)
is restricted tobeconstantwithin theelements
ofthis partition, then 0 can be estimated in a
computationally simple fashion using Poisson
regression methods. See Preston et al. (24)
for application ofsuch methods to radiation
dose-response estimation from the Hiroshima
andNagasakicohorts.
Particular care is required ifthese estima-
tionprocedures are applied to cohorts having
few cases or if most cases occur within a
small portion of the overall range of expo-
sures. Asymptotic formulae for interval esti-
mation on P may then be inaccurate and
more specialized procedures (e.g., resampling
methods) maybe required. In fact, there has
been little study of cohort data configura-
tions underwhich such asymptotic formulae
willprovideadequateapproximations.
Kalbfleisch and Prentice (3) and Cox
and Oakes (4) provide detailed accounts of
the theory and application of relative-risk
regression models.
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Ao,(t) = I to,(u)du, [10]
the cumulative baseline disease rate in stra-
tum s in the stratified model of "Relative-
Risk Models" over the range ofages t2 tos
represented in the cohort. A simple non-
parametric estimator ofAo,(t) can then be
defined as the sum over all disease occur-
rence times in stratum s ofthe ratio ofthe
number ofstratum s failures to the sum of
the relative risks for all subjects at risk in
stratum sat that time, with all relative risks
evaluated at that 3 which maximizes L(,).
As with ordinary regression methods,
model-checking procedures are important
to the application ofrelative-risk and odds-
ratio models. Such procedures naturally
focus on the assumed relative-risk process,
exp{X(t)P}, because other aspects of the
model essentially are nonparametric. For
example, the postulated relative-risk func-
tion can be generalized by adding
well-selected additional elements to X(t)
and testing the hypothesis that correspond-
ing coefficients equal zero. Computationally
feasible methods also have been developed
for approximating the influence of each
study subject or each age group on P-esti-
mation, in order to highlight questionable
data points and to highlight vulnerabilities
of the inference to model assumptions
(25). Graphical procedures particularly
are useful. In addition to the usual types of
plots of influence (i.e., sensitivity) values
and residuals, plots ofseparate estimates of
Aos(t) for subsets of the cohort can pro-
vide useful visual checks on proportionality
and other relative-risk assumptions (3).
The fact that the baseline rates kos(e)are
unrestricted is an important source ofrobust-
ness in respect to -etiimation. Specifically,
relative-risk estimation is unlikely to be
affected much ifthe intensity of ascertain-
ment of disease events in the cohort varies
somewhat across time or among strata.
Similarly, location shifts in the modeled
regression vector X(t) across different values
of twould not affect [-estimation in the
exponential-form relative-risk model.
However, more general measurement error
in the ascertainment of X(t) may have a
profound effect on relative-riskestimation.
Measurement Errorin u re
Variables andConfunding E s
Epidemiologists have long recognized that
errors in the measurement of the study
variables, induding misdassification in the
caseofcategorical variables, canlead to biased
tests and estimates ofthe associations under
study. Measurement error in the exposure
histories or confounding factor histories may
be ofparticular importance in environmental
epidemiologic applications. Unfortunately,
the methodology for avoiding bias due to
measurement error is still at a rudimentary
stageofdevelopment.
Consider the unstratified relative-risk
regression model of "Relative-Risk Models"
and suppose that rather than the covariate
history Z(t) one observes an estimate W(t).
The disease rate function at age (or chrono-
logical time) t, given the observed covariate




where the expectation also is conditional
on lack ofdisease occurrence or censorship
prior to t. In fact, this induced relative-risk
model also requires
X{t;Z(t),W(t)} = {t;Z(t)} [12]
so that the W(t) is unrelated to disease risk,
given the true covariate history Z(t).
Unfortunately, the expectation in X{t;W(t)}
generallydepends onthe baseline rates 0(u),
u . t, which complicates the estimation.
However, in cohort studies in which the
cumulative probability ofdisease occurrence
is small, this dependence usually can be
ignored and estimation of,B can be based on
a likelihood function in the form described
above upon specifying a measurement error
distribution forX(t) given W(t), fromwhich
X{t;W(t)} canbecalculated.
Specification of the distribution ofX(t)
given W(t) would seem to be a hazardous
undertaking unless there is a subsample in
which both Z(t) and W(t) are available. In
the presence of such a validation sample,
simultaneous inference on relative-risk para-
meters and measurement error distribution
parameters is possible (27), though further
development is necessary before such estima-
tion can be viewed as routine. More difficult
issues arise ifa true validation sample is not
available. Areliability sample, inwhich sepa-
rate estimates W1(t) and W2(t) ofZ(t) are
obtained on a cohort subsample at two (or
more) points in time, permits insight into
some aspects ofmeasurement error distribu-
tion, but additional strong assumptions are
requiredfortheestimation of,.
Even if the exposures under study are
precisely estimated and pertinent con-
founding factors are identified, severe con-
founding may occur if confounding factor
histories are measured with error (28), as is
obvious if one considers an extreme situa-
tion in which measurement error produces
a totally useless confounding factor esti-
mate. This bias is likely to be more acute if
the exposure and confounding factorvalues
appearing in X(t) are highlycorrelated.
A hypothetical cohort study of prenatal
exposure to passive smoking in relation to
the risk oflower respiratory disease during
the first 3 years oflife provided illustration
in Morgenstern and Thomas, this volume.
Any elevation in the odds oflower respira-
tory disease among more heavily exposed
neonates may be severely attenuated by
inaccuracies in exposure assessment in such
a study. An analysis that controls for pas-
sive smoke exposure during the first 3 years
of life, an exposure that would often be
highly correlated with prenatal exposure,
may be dominated by measurement error
and be totally unreliable. A more practical
illustration of the impact of measurement
error is seen in the analysis ofthe mortality
rates of various cancers in relation to
gamma and neutron exposures in the
HiroshimaandNagasakicohorts. Individual
exposure estimates were constructed based
on each study subject's location and shield-
ing information as early as 1960. These
estimates have continued to be refined in
succeedingyears through the useofimproved
models for the yields ofthe two bombs and
more sophisticated models for the forma-
tion, transmission, and attenuation of
gamma and neutron radiation. Many of
the analyses of these cohorts simply com-
bine gamma and neutron exposures into a
single total dose estimate. The correspond-
ing cancer mortality analyses have been
affected somewhat by the changes in total
dose estimates from one dosimetry system
to the next (e.g., in the magnitude of ele-
vated relative risks and the apparent shape
of the dose-response curves), whereas
analyses that attempt to estimate simulta-
neously the effect of gamma and neutron
exposures on relative risk have been com-
pletely changed by dose estimate modifica-
tions. This illustrates the difficulty of
reliably estimating exposure-disease associa-
tions when there are two or more exposure
variables that are each measured with error
(random or systematic) or, analogously,
when there are exposure and confounding
variables each measured with error. Very
similar issues arise in epidemiologic studies
of nonenvironmental factors; for example,
theyarise in attempts to separatetheeffectsof
fat and calories on cancer risk in nutritional
epidemiology, or to separate the effects of
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types offat bydegree ofsaturation on cancer
risk in nutritional epidemiology (29).
Some recent work has concentrated on
developing methods to adjust associations
for the effects ofmeasurement errors when
their distributions are known. A very gen-
eral framework for attacking this problem
has been outlined by Clayton (30), who
specifies the problem in terms of compo-
nent models: the disease model describes
the dependence of disease risk on true
exposures and other factors; the measure-
ment error model describes the relationship
between true and measured exposures and
any modifying factors; and the exposure
model describes the population distribu-
tion oftrue exposures. These three models
are combined in a maximum likelihood
framework, and approaches to estimating
the parameters of the disease model are
described. Unfortunately, the approach is
mathematically intractable in its general
form, but useful progress has been made in
some special cases. For categorical vari-
ables, Greenland and Kleinbaum (31)
described a method based on applying the
inverse of a matrix ofknown misclassifica-
tion rates to the subject counts by mea-
sured exposure and disease classifications.
Hui and Walter (32) have considered the
case in which replicate measurements of
exposure are available, and they use a form
of log-linear model for the resulting
four-way contingency table (counting true
exposure as an unobserved dimension).
For continuous variables, Prentice (26),
Pierce et al. (33), Whittemore (34),
Sposto et al. (35), and others have dis-
cussed approaches that replace the mea-
sured doses with empirical Bayes estimates
of the true dose and use these in standard
analyses. For a general review of these
approaches, see Armstrong (36) and
Thomas et al. (37). Another recent devel-
opment involves combining nonparametric
density estimation techniques with a com-
putational device known as Gibbs sampling
to overcome the tractability problems in
the Clayton approach and avoid the need
for parametric assumptions about the dis-
tribution of true doses. This method has
been applied to data on studies ofleukemia
and thyroid disease in Utah residents
downwind of the Nevada Test Site
(38,39). These approaches are in an early
stage of development, but they offer the
prospect of removing the bias due to mis-
classification, correcting the shapes of
dose-response curves, adjusting for covari-
ates, and examining interaction effects, all
while allowing for the additional uncertain-
ties due to uncertainties in exposure esti-
mates. Further developments along these
lines are highly desirable.
Most of the literature on correcting for
measurement errors has assumed that the
misdassification rates were known and were
constant across subjects. In practice, only
estimates ofthese errordistributions are avail-
able, either from earlier validation studies,
from replicate measurements, from gold stan-
dard measurements on a subset of the sub-
jects, or from theoretical uncertainty analysis.
Methods need to be developed to account for
uncertainties in the estimates ofthese misclas-
sification rates (40). As a design issue, the
optimal allocation ofresources between high-
quality measurements on a subset and larger
numbers of approximate measurements
should be considered (41,42). A unique
aspect ofthe Utah fallout studies is the avail-
ability ofindividual-specific uncertainty esti-
mates based on elaborate sensitivity analyses
ofthe exposure pathways. This has allowed
subjects with more precise exposure estimates
to be given heavier weight in the analysis.
Whether such efforts are warranted in terms
ofimproved precision needs to beconsidered.
In summary, covariate measurement
errors can bias severely the results of envi-
ronmental epidemiologic studies. Improved
analytic methods for accommodating ran-
dom, nondifferential covariate measurement
errors are required. Such methodologic
developments might naturally focus on the
potential for obtaining a true validation
sample, on validation study design, and on
the incorporation ofvalidation study data in





Relative-risk and odds-ratio estimation
often can be carried out more economically
by sampling only subjects developing the
study disease (the cases) or a random sam-
ple thereof, along with a suitably matched
sample of subjects without disease (the
controls). Typically covariate histories
Z(t), where t is the age (time) of case or
control ascertainment, then have to be
obtained retrospectively.
Consider the stratified relative-risk model
of "Relative-Risk Models" and suppose that
each case has one or more randomly selected
controls that are matched on age at ascertain-
ment (t) and stratum (s). Given the covari-
ate histories {Z1(t),..., Zm(t)} for a case and
its (rn1) age- and stratum-matched controls,
the probability that exposure history Z1(t)
corresponds to the case is simply the relative
risk at t for the case divided by the sum of
such relative risks for the n-matched subjects
(including the case). Hence, the relative-risk
parameter , can be estimated by maximizing
the likelihood function L(f3), which is
formed by multiplying these ratios for all
matched case-control sets (43). To avoid
strict matching on (t,s), relaxations of this
samplingschemearepossible.
Similarly, the odds-ratio parameter P in
the logistic regression model of "Relative-
Risk Models" can be estimated under
case-control sampling by maximizing the
resulting logistic regression likelihood func-
tion by acting as though a prospective
study had been conducted, though the esti-
mates of as no longer reflect disease inci-
dence probabilities (23). In fact, the
baseline rates XOs(@) and axs in the relative-
risk and odds-ratio regression models of
"Relative-Risk Models" cannot be identified
from case-control data in the absence of
additional information on case and control
samplingfractions.
In general, relative-risk and odds-ratio
parameter estimates from case-control
studies will be subject to the same biases as
cohort studies. They also may be subject
to recall bias ifexposures or other covariate
histories are differentially recalled by cases
and controls or if they involve measure-
ments that are affected by disease occur-
rence or its sequelae. There are often
various practical steps that can be taken to
minimize bias in ascertaining the covariate
histories Z(t) (e.g., interviewers blinded to
case or control status), but usually it is not
possible to identify residual recall bias
because the requirement to obtain prediag-
nosis and postdiagnosis covariate histories
on a sufficient sample ofcases would often
eliminate much of the efficiency of the
case-control design.
As with the cohort study design, nondif-
ferential measurement errors lead to the
expectation
E[exp{X(t)} I W(t)]' [13]
where X(t) is the true and W(t) is the mea-
sured regression vector at age t, as the identi-
fiable relative-risk function under age- and
stratum-matched case-control sampling. To
the extent that a representative validation
sample can be ascertained retrospectively,
therewill be apotential to conductvalid rela-
tive-risk estimation from this type of study
withoutmakingfurtherassumptions.
A case-cohort (case-base) sampling pro-
cedure can also be considered as a means of
reducing the cost or simplifying the logis-
tics of a cohort study. With this design,
covariate histories Z(t) are assembled only
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for cases and a (stratified) random sample
ofthe study cohort. This sampling proce-
dure has advantages if several end points
(diseases) are to be studied in relation to an
exposure. Also, the subcohort may be used
to monitor exposures and other variables
during the study's follow-up. However,
estimation may be less efficient than esti-
mation based on a case-control study with
a comparable number of study subjects if
cases and subcohort members are not well
matched (44,45), and recall bias typically
will be an issue. Prentice (46) has developed
a procedure for estimating the relative-risk
and odds-ratio parameters from case-cohort
samples, and, incontrastto case-control sam-
pling, baseline rates also can be estimated
without external information. Comparisons
and refinements of these sampling proce-
dures areworthwhile research activities. Note
also thatthe useofso-calledtwo-stage designs
(47,48) can lead to furthervaluable efficiency
gains insomecase-controlstudyapplications.
Exposure-esponse
Estimation in Aggregate Data
(Ecologic) Studies
As discussed previously, sometimes it will be
economical and convenient to examine an
exposure-disease association by relating the
disease rates among several groups of indi-
viduals to aspects ofthe exposure experience
ofeach group. Such studies can be referred
to as aggregate data studies since they
involve the disease rates and exposures for
the aggregate, rather than for individuals.
These studies also are commonly referred to
as ecological studies since groups having dif-
fering exposure histories are sometimes
defined on an ecologic orgeographic basis.
Denote by Xki(t) the age- and sex-spe-
cific disease rate in the kh group during
(chronological) time period t. A multiple
group study involves the analysis of esti-
mates ofXki(t), k = 1,...,Kduring a fixed
time period; a time trend study involves
estimates ofXki(t), t = 1,...,Tin a single
population, while a mixed study involves
estimates ofXki(t) at several values ofboth
k and t. An exponential-form relative-risk
model for Xki(t) can be written, in the
notation of"Relative-RiskModels," as
Xki(t) = Xko(t)exp{Xki (t)13}, [14]
from which the average disease rate Xk(t)
for the nk(t) individuals in group kduring
time period tis
nk(t)







Xk(t) = nk (t)Xki(t)
and
dki(t) = Xki(t) - Xk(t) [17]
Letyk(4 denote theobserved age- andsex-spe-
cific dise incidence rate in group k during
time period t as may be available from a dis-
ease register or other admininstrative source.
From the above expression for Xk(t), one
expects a regression oflogYk(t) on Xk(t) for
variousvaluesofkor t(orboth) toyieldbiased
extimates of the relative-risk parameter P,
because of the influences ofthe residuals
dki(t), even ifthe logarithms ofthe baseline
rates Xko(t) can be regarded as independent
randomvariableswith acommon mean. This
specification biaswill besmall ifthedki(t) val-
ues aresmall, that is, iftheexposure andother
regression variables have little variation within
groups. Such bias presumablycan be reduced
by extending the regression equation to
indudeaverages ofsquares andofhigherpow-
ers ofthe dki(t) terms, though there does not
appear to have been specific study of this
approach. A dosely related approach would
replace the exponential-form relative-risk
modelbyalinear-form model,sothat
and Xki(t) = XkO(t){ 1 + Xki (t)13} [18]
Ak(t) = XkO(t){1 + %*(t)*} [19]
from which the regression ofyk(t) onXk(t),
under certain random-effects assumptions on
the baseline rates {kko(t)}, will yield valid
estimates ofthe linear relative-risk parameters
(49). Note, however, that an exponential-
form relative-risk model often might be more
parsimonious than a linear-form model in
environmental epidemiologic applications so
that the regression vector in a linear relative-
risk model may need to be quite lengthy and
involve, for example, the average ofproduct
terms between exposure and potential con-
founding factors in order to adequately
describe the data. In a multigroup study, it
maybesensible to assume theko(t) termsare
independent random variables with a com-
mon mean for k = 1,...,K thought it often
may be useful to allow for the possibility of
correlation among groups in a similar geo-
graphic area. In time-trend and mixed stud-
ies, however, it will typically be essential to
model, orotherwise accommodate, the corre-
lation structure amongXko(t), t= 1,...,Tat
any fixed k. Inadequate modeling of the
{Xko(t)} may lead to aggregation bias.
These types ofdata analysis methods have
received very little attention in the scientific
literature and constitute an important gap in
the collection ofmethods pertinent to envi-
ronmental epidemiologic applications.
Aggregate data studies involving the sim-
ple linear regression ofdisease rates or the
logarithm ofdisease rates on average expo-
sures and average values of potential con-
founding factors can often be conducted
quickly and cheaply and can play a useful
role in hypothesis generation. It is obvi-
ous, however, that more comprehensive
data sources and more sophisticated data
analyses typically will be required if aggre-
gate data studies are to contribute reliably
to the identification and estimation of
exposure-disease associations. Better data
could come from randomly sampling each
ofthe compared groups in order to obtain
estimates, Xk(t) of acceptable precision for
use in alinear relative-risk model or to obtain
estimates ofthe average ofexp{Xki(t)P}, i =
L,...,nk(t) for use in an exponential relative-
risk model. Random measurement error in
the ascertainment of individual exposure
and confounding factors could impact sub-
stantially survey design. Better data analy-
ses may arise from the application of
so-called marginal methods (50,51) to
mean and covariance models for the set of
yk(t) or logyk(t) valuesbeinganalyzed.
Most effort to date concerning aggregate
data studies has been directed to identifying
the biases that may arise from aggregation,
confounding, and other sources (52,53). It
seems timely to direct a major effort to the
development ofprocedures to prevent (or
greatly reduce) such biases and, hence, to
evaluate whether aggregate data studies can
play a more fundamental and useful role in
environmental epidemiologic studies and in
epidemioligic research moregenerally.
Comparing and Combining
the Results ofSeveral Studies
Studies ofa certain exposure-disease associa-
tion may, for a variety ofpractical reasons,
be lacking in power, and they may be sub-
ject to biases that can differ according to the
population under study, the type of study
design, and the rigor ofthe investigation. It
follows that tests of agreement among the
results of various studies and the formal
combining ofresults from pertinent studies
can play an important role in an overall
exposure-disease association assessment.
Under ideal conditions, each ofthe types
ofstudies described above can yield a valid
estimate0ofthelogarithm ofthe relative risk
associated with a specified exposure history,
as well as an estimate62 ofits variance. The
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logarithm is used here, because its estimate is
likely to adhere more dosely to a normal dis-
tribution (with mean j) than the estimate dP
oftherelative riskitself. Suppose m-indepen-
dentstudiesyield (scalar) log-relative riskesti-
mates of ,...,02with correspondingvariance
estimatesap...,-2
a= aIX -i [20]
estimates a weighted mean of ,i's, which
reduces to a common 3 ifall Pi3's are iden-
tical. To obtain the most stable estimate of
this common mean, one can follow devel-
opments arising from Cochran's (54)
introduction of partial weighting, thereby
avoidingweights & i . ( -, which maybe
too small.




A &i(0, 5)2 [1 [21]
will have a chi-square distribution with
m-1 degrees of freedom, thereby giving a
simple test of"all pi = [" (assuming eachOi
is distributed normally). Ifthe i's are not
identical, then a t-procedure can be used to
set confidence limits for theweighted mean
5 = & -i2i l &-i2 [22]
Confidence limits on are approximately
0i t CY&-i2) -2 [23]
where tv is a critical value of t on v (some-
what less than m) degrees offreedom. These
limits are often conservative, particularly
when the 3ifollowlonger-tailed distributions.
There are various reasons why the chi-
square test described may provide evidence
ofheterogeneity ofthe relative-risk estimates
from the m studies. For example, studies of
the same type (e.g., r-cohort studies) may
have differentially controlled for confound-
ing or may have defined and measured
exposure differently. Studies of different
types (e.g., m-cohort, case-control and
aggregate studies) have different sources of
potential bias, for example, recall bias for
case-control studies and aggregation bias in
ecologic studies. Hence, it may be useful
first to contrast and combine studies ofthe
same type and then to examine whether the
summary estimates of0 from each study
type are heterogenous. In respect to studies
ofthe same type, the overview, or metanaly-
sis, may be strengthened by analyzing the
raw data from each study in a uniform for-
mat, which would maximize their compa-
rability in terms of confounding control
and exposure modeling. A fundamental
principle of such analyses is that the para-
meter estimate0 is based only on the com-
bination ofwithin-study information, as is
the case for the heterogeneity test and the
log-relative riskestimate described above.
Measurement error in exposure and in
covariate assessment may be a particularly
important source of heterogeneity among
relative-risk estimates. For example, ran-
dom measurement error may attenuate
severely or otherwise distort relative-risk
estimates in a cohort or case-control study
if, for example, exposure assessment is
based on data provided by individual inter-
views (e.g., location and shielding informa-
tion in the Hiroshima and Nagasaki
cohorts), but such attenuation may not be
an issue in an aggregate data study if the
desired averages (see "Exposure-Response
Estimation inAggregate Data Studies") can
be estimated precisely. In this circum-
stance, some effort to deattenuate the ana-
lytic study relative-risk estimates, or to
attenuate equally the aggregate data rela-
tive-risk estimates, is essential prior to the
comparison of these estimates. See
Prentice and Sheppard (55) for a recent
attempt to study the consistency ofinterna-
tional disease rate, time-trend, case-control
and cohort studies in the dietary carcino-
genesis area. Note also that will be
biased as an estimator of i if the available
log-relative risk estimates OMl. 5m are a
biased sample of estimates from existing
studies, which may arise ifthere is so-called
publication bias in which relative-risk esti-
mates that are significantly different from
unity are more likely to be reported in the
scientific literature. SeeYusufetal. (56) for
a discussion ofsome issues in the conduct of
such metanalyses.
Other Data AnalysisTopics
The above presentation emphasized time to
disease endpoints and corresponding relative-
risk and odds-ratio models. In some areas of
environmental epidemiologic research (e.g.,
respiratory epidemiology or neuroepidemi-
ology), important endpoints are continu-
ous. Much of the corresponding data
analysis methodology is well established
and does not need to be discussed here.
However, methods for handling measure-
ment error with continuous data (57) also
require much additional development.
Recent advances in the methods for analy-
sis of longitudinal data (50) for discrete or
continuous data are also quite relevant to the
analysis ofcertain types of environmental
epidemiologicdata.
Preceding sections also have not addressed
the simultaneous analysis oftwo or more end-
points. Forexample, in respiratoryepidemiol-
ogy, there may be several measures oflung
function, and a data analysis goal may be to
summarze exposure effects over several corre-
lated measures ofchange in lung function.
The estimating equation approaches men-
tioned above (50,51) provide an approach to
such problems with discrete or continuous
outcomes, butworkcouldbedonetocompare
these methods to univariate methods based on
some summary endpoint. Methods for the
analysisofcorrelatedfailuretimedatacurrendy
are not well established, though much statisti-
cal research is underway presently. See, for
example, Clayton and Cuzick (58), Wei et al.
(59), and Prentice and Cai (60) for recent
contributions. Correlated failure-time meth-
ods also are required for the investigation of
genetic factors or gene-environment interac-
tions undercertain typesofstudydesigns. For
example, in a pedigree cohort study, it typ-
ically will be essential to allow for depen-
dence between the disease occurrence times
offamily members when studying environ-
mental exposure effects in relation to
genetic indicatorsofsusceptibility.
Morgenstern andThomas, in thisvolume,
mention certain designs other than those dis-
cussed thus far in this artide, as well as the
use ofbiomarker endpoints. Corresponding
data analysis issues and methods will be
mentioned onlybrieflyhere.
It was noted that experimental designs are
practical occasionally in environmental epi-
demiologic research. The relative-risk and
odds-ratio regression methodsdescribedabove
apply equally well for the comparison ofdis-
easeincidence (ormortality) ratesbetweenran-
domization groups in individually randomized
designs. However, agroup-randomizeddesign
(e.g., with community as the unit ofrandom-
ization) is more likely to be feasible, in which
case it is essential to acknowledge thepossibil-
ity ofcorrelation among the responses (e.g.,
disease incidence times) ofsubjects in the
same randomization group, which require the
use of the type of correlated failure-time
methodsmentionedabove.
In the discussion ofecologic designs itwas
noted that descriptive studies ofthe cluster-
ingofdisease (e.g., in space or time) can play
a useful role in the generation of environ-
mental health hypotheses. These types of
studies also have specialized data-analytic
issues and methods. Statistical analysis has
little to offer in the event ofan isolated dus-
ter discovered by ad hoc methods. Clusters
within which the disease counts substantially
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exceed expected counts perhaps are best
addressed by direct fieldwork to identify a
putative cause. On theotherhand, hypothe-
ses of a general tendency to cluster can be
addressed statistically by using methods
that compare the number of cases in cer-
tain neighborhoods of each case to the
expected number ofcases, while also taking
account of population density. Local
neighborhood tests also are available with
case-control sampling. See Rothman (61)
andotherpapers inthisvolumefordiscussions
ofdisease-clustering methods.
The design chapter (in this issue) also
emphasizes cross-sectional studies for the
estimation ofprevalence rates. The logistic
regression methods outlined in "Relative-
Risk and Odds-Ratio Estimation" may be
used to relate prevalence probabilities to
retrospectively obtained exposure and con-
founding factor histories. Ofcourse, such
prevalence probabilities reflect aspects of
both disease incidence and disease dura-
tion, and therefore, may be difficult to
interpret. Keiding (62) provides a compre-
hensive discussion of the relationships
between prevalence probabilities, incidence
rates, and disease durations and ofthe pos-
sibility ofderiving estimates ofage-specific
incidence from cross-sectional studies.
As discussed previously, biomarkers may
serve usefully as exposure indicators or as
early indicators of disease (see Hatch and
Thomas, this volume). An example of a
biomarker as an intermediate endpoint is
seen in chromosomal abnormalities in the
radiation-exposed cohorts ofHiroshima and
Nagasaki. The rates ofsuch abnormalities
among long-lived lymphocytes (usually 100
cells examined for each subject) have played
a useful role in assessing the health effects of
radiation exposure in these populations.
The correlation among the chromosomal
events in cells from the same study subject
has a strong influence on dose-response
analyses in this application (35,63). Recent
advances in the ability to study the cellular
and molecular mechanisms involved when
responding to exposure and disease patho-
genesis will lead inevitably to greater use of
biomarkers and biological measurement in
environmental epidemiologic studies.
Hence, data analysis methods that incorpo-
rate such measurements in a biologically
meaningfud fashion are required. Suitable
methods for dose-response analysis with
biomarker endpoints will vary according to
the type of endpoint(s) involved. Recent
estimating equation approaches (50,51)
often may be useful for such analyses.
Circumstances under which a biomarker
endpoint can substitute for disease occur-
rence and yield valid dose-response tests
and estimates is also of considerable inter-
est. See Prentice (64) for the introduction
and discussion ofsuch criteria.
Finally, it seems worth noting that the
interpretation ofrelative-risk estimates from
astudy maydepend on priorknowledge and
on studygoals. Forexample, ifsuch estima-
tion takes place in the context of a study
specifically designed to confirm a particular
association, the corresponding tests and con-
fidence intervals are more appropriately
taken at face value than ifthe relative risk is
estimated in a purely exploratory context
wherein various other exposures also are
examined in relation to disease risk. In this
latter situation, formal methods maybe used
to acknowledge the multiple hypotheses
being examined, but precise statistical meth-
ods for doing so in a general way are not
available. (So-called Bonferroni methods
are available widely and may be precise
enough.) Also, one is often neither in a
purelyexploratorynor apurelyconfirmatory
mode in data analysis.
Summary
Recommendations
Perhaps the single most important data
analysis research need in environmental
epidemiology concerns the development of
improved methods to accommodate mea-
surement errors in exposure assessment.
Efforts aimed at the design and use ofvali-
dation studies would be particularly useful,
as would studies to document the scope and
magnitude ofmeasurement error influences.
A second important need concerns
improved methods for the conduct and
analysis ofaggregate data (ecologic) studies.
The development of strategies for control-
ling potential confounding, particularly by
using individual surveys in multigroup
studies, along with corresponding innova-
tive data analysis methods, will be impor-
tant. Empirical studies that illustrate
various analytic and aggregate data analyses
ofreal datasets also would bevaluable.
Other pertinent topics for data analysis
reechindudethedevelopmentofimproved
methods for meta-analyses when studies of
different types with differing potential for
measurement error biases are available, the
development offlexible data analysis meth-
ods, and the study ofproperties ofanalyses
based on biomarker indicators of exposure
or biomarker end points. Studies that eval-
uate and compare strategies for the control
of confounding also merit continuing
attention in environmental epidemiology
as in other observational research areas.
Further work on biologically based mathe-
matical models for cancer and for other
disease also would bewell motivated. en
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